Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 102417
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.102417
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.102417
Table 1 Clinicopathologic characteristics of 36 patients with colorectal cancer
Characteristics | 5-Fu-sensitive group (n = 22) | 5-Fu-resistant group (n = 14) | P value |
Age (years) | |||
< 60 | 3 | 2 | 1.000 |
≥ 60 | 19 | 12 | |
Sex | |||
Male | 14 | 9 | 1.000 |
Female | 8 | 5 | |
Tumor size | |||
< 5 cm | 17 | 9 | 0.462 |
≥ 5 cm | 5 | 5 | |
Location | |||
Colon | 14 | 6 | 0.307 |
Rectum | 8 | 8 | |
Differentiation | |||
Well/moderate | 15 | 10 | 1.000 |
Poor | 7 | 4 | |
Tumor depth | |||
T1 + T2 | 3 | 2 | 1.000 |
T3 + T4 | 19 | 12 | |
AJCC stage | |||
II | 10 | 4 | 0.485 |
III | 12 | 10 | |
SNHG5 expression | |||
Low | 17 | 5 | 0.018a |
High | 5 | 9 |
- Citation: Wang B, Zhou Q, Cheng CE, Gu YJ, Jiang TW, Qiu JM, Wei GN, Feng YD, Ren LH, Shi RH. Long noncoding RNA SNHG5 promotes 5-fluorouracil resistance in colorectal cancer by regulating miR-26b/p-glycoprotein axis. World J Gastrointest Oncol 2025; 17(5): 102417
- URL: https://www.wjgnet.com/1948-5204/full/v17/i5/102417.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.102417